Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

Exciting news on the treatment front as Aravax's peptide treatment for peanut allergy receives FDA Fast Track designation. If successful, the platform can be repurposed to treat other food allergies.

Fecal Transplants Reveal a New Path Toward Peanut Allergy Treatment

Super exciting news as researchers zero in on the components of the gut microbiome that confer allergen tolerance, opening the door to the development of new, targeted treatments.

Outrage as FAA Again Declines to Mandate Epinephrine Auto-Injectors

Awful news as the FAA AGAIN refuses to mandate epinephrine devices like auto-injectors and nasal sprays, instead allowing airlines to maintain vials of the drug with syringes that require training to draw and administer.

Breakthroughs on the Horizon: FAF Funds Five New Studies Targeting Food Allergies

A wave of breakthrough science is taking aim at food allergies, with the Food Allergy Fund pouring fresh backing into five cutting-edge studies. By harnessing artificial intelligence, deep immune biology, precision nutrition, and the gut microbiome, these projects will supercharge the search for game-changing treatments and an ultimate cure.

Court Ruling Dismisses Anaphylaxis Product Liability Claim

Although this claim seemed a bit dubious from the start, it highlights the high bar for lawsuits claiming liability for anaphylaxis. What do you think? Let us know in the comments section.

FASTER Act of 2026 Introduced to Target Hidden Gluten Sources in Food Labels

This bill would significantly help people with celiac disease and gluten intolerance avoid gluten, but it also marks a missed opportunity to improve our flawed allergen-labeling rules.